The Vanguard Group just provided an update on share ownership of PDL BioPharma

The Vanguard Group just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though The Vanguard Group claims to own 13,352,288 shares. This represents 8.06% of PDL BioPharma.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever PDL BioPharma makes a similar move, sign up!

Other recent filings from the company include the following:

Departure of Directors or Certain - June 14, 2018
PDL BioPharma director just picked up 54,348 shares - June 12, 2018
PDL BioPharma director just picked up 54,348 shares - June 12, 2018
PDL BioPharma's CEO was just granted 1,922,100 options - June 12, 2018
PDL BioPharma director just picked up 54,348 shares - June 12, 2018

Auto Refresh

Feedback